Research ArticleArticle
Disease Factors in Early Rheumatoid Arthritis Are Associated with Differential Risks for Cardiovascular Events and Mortality Depending on Age at Onset: A 10-year Observational Cohort Study
Sofia Ajeganova, Maria L.E. Andersson, Johan Frostegård and Ingiäld Hafström
The Journal of Rheumatology August 2013, jrheum.130365; DOI: https://doi.org/10.3899/jrheum.130365
Sofia Ajeganova
From the Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm; R and D Centre, Spenshult Hospital for Rheumatic Diseases, Oskarström and Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund; Unit of Immunology and Chronic Disease, Institute of Environmental Medicine, Karolinska Institute, Stockholm; Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden. Supported by grants from The Swedish Rheumatism Association, King Gustav V 80 year’s Foundation, the Swedish Research Council, and the Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and the Karolinska Institute. S. Ajeganova, MD, PhD, Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge; M.L.E. Andersson, BSc, PhD, R and D Center, Spenshult Hospital for Rheumatic Diseases, Oskarström and Department of Clinical Sciences, Section of Rheumatology, Lund University; J. Frostegård, MD, PhD, Professor, Unit of Immunology and Chronic Disease, Institute of Environmental Medicine, Karolinska Institute; and I. Hafström, MD, PhD, Professor, Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge. Address correspondence to Dr. S. Ajeganova, Unit of Rheumatology, R92, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden. E-mail: sofia.ajeganova@karolinska.se. Accepted for publication July 2, 2013.
Maria L.E. Andersson
From the Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm; R and D Centre, Spenshult Hospital for Rheumatic Diseases, Oskarström and Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund; Unit of Immunology and Chronic Disease, Institute of Environmental Medicine, Karolinska Institute, Stockholm; Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden. Supported by grants from The Swedish Rheumatism Association, King Gustav V 80 year’s Foundation, the Swedish Research Council, and the Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and the Karolinska Institute. S. Ajeganova, MD, PhD, Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge; M.L.E. Andersson, BSc, PhD, R and D Center, Spenshult Hospital for Rheumatic Diseases, Oskarström and Department of Clinical Sciences, Section of Rheumatology, Lund University; J. Frostegård, MD, PhD, Professor, Unit of Immunology and Chronic Disease, Institute of Environmental Medicine, Karolinska Institute; and I. Hafström, MD, PhD, Professor, Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge. Address correspondence to Dr. S. Ajeganova, Unit of Rheumatology, R92, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden. E-mail: sofia.ajeganova@karolinska.se. Accepted for publication July 2, 2013.
Johan Frostegård
From the Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm; R and D Centre, Spenshult Hospital for Rheumatic Diseases, Oskarström and Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund; Unit of Immunology and Chronic Disease, Institute of Environmental Medicine, Karolinska Institute, Stockholm; Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden. Supported by grants from The Swedish Rheumatism Association, King Gustav V 80 year’s Foundation, the Swedish Research Council, and the Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and the Karolinska Institute. S. Ajeganova, MD, PhD, Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge; M.L.E. Andersson, BSc, PhD, R and D Center, Spenshult Hospital for Rheumatic Diseases, Oskarström and Department of Clinical Sciences, Section of Rheumatology, Lund University; J. Frostegård, MD, PhD, Professor, Unit of Immunology and Chronic Disease, Institute of Environmental Medicine, Karolinska Institute; and I. Hafström, MD, PhD, Professor, Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge. Address correspondence to Dr. S. Ajeganova, Unit of Rheumatology, R92, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden. E-mail: sofia.ajeganova@karolinska.se. Accepted for publication July 2, 2013.
Ingiäld Hafström
From the Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm; R and D Centre, Spenshult Hospital for Rheumatic Diseases, Oskarström and Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund; Unit of Immunology and Chronic Disease, Institute of Environmental Medicine, Karolinska Institute, Stockholm; Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden. Supported by grants from The Swedish Rheumatism Association, King Gustav V 80 year’s Foundation, the Swedish Research Council, and the Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and the Karolinska Institute. S. Ajeganova, MD, PhD, Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge; M.L.E. Andersson, BSc, PhD, R and D Center, Spenshult Hospital for Rheumatic Diseases, Oskarström and Department of Clinical Sciences, Section of Rheumatology, Lund University; J. Frostegård, MD, PhD, Professor, Unit of Immunology and Chronic Disease, Institute of Environmental Medicine, Karolinska Institute; and I. Hafström, MD, PhD, Professor, Unit of Rheumatology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge. Address correspondence to Dr. S. Ajeganova, Unit of Rheumatology, R92, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden. E-mail: sofia.ajeganova@karolinska.se. Accepted for publication July 2, 2013.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Disease Factors in Early Rheumatoid Arthritis Are Associated with Differential Risks for Cardiovascular Events and Mortality Depending on Age at Onset: A 10-year Observational Cohort Study
Sofia Ajeganova, Maria L.E. Andersson, Johan Frostegård, Ingiäld Hafström
The Journal of Rheumatology Aug 2013, jrheum.130365; DOI: 10.3899/jrheum.130365
Disease Factors in Early Rheumatoid Arthritis Are Associated with Differential Risks for Cardiovascular Events and Mortality Depending on Age at Onset: A 10-year Observational Cohort Study
Sofia Ajeganova, Maria L.E. Andersson, Johan Frostegård, Ingiäld Hafström
The Journal of Rheumatology Aug 2013, jrheum.130365; DOI: 10.3899/jrheum.130365